Internal Medicine · Perry, GA
NPI
1912951500
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
6
Medicare group memberships
Hospitals
3
Hospital affiliations
1115 Morningside Dr
Perry, GA, 31069
Phone (478) 988-3060
Groups this clinician bills Medicare through
Medicare paid, 2024
$481K
9,024 services
Medicare patients, 2024
586
Average age 78
Drug cost, 2024
$4.4M
132,362 prescriptions
Company payments, 2025
$742
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Appavuchetty Soundappan was code 99308 (snf e&m), 1,717 times for 258 patients. In total Appavuchetty Soundappan billed 9,024 services in 60 codes, and Medicare paid $481K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-02-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99308 SNF E&M | Facility | 1,717 | 258 | $53.75 | $92K |
| 99214 Office E&M - Established | Office | 1,128 | 214 | $86.28 | $97K |
| 99457 E&M - Miscellaneous | Office | 802 | 100 | $36.39 | $29K |
| 99213 Office E&M - Established | Office | 641 | 180 | $60.48 | $39K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 532 | 184 | $12.66 | $6,734 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 512 | 99 | $47.38 | $24K |
| 99454 E&M - Miscellaneous | Office | 487 | 81 | $33.25 | $16K |
| 99489 Chronic, Principal, and Transitional Care Management | Office | 444 | 73 | $53.47 | $24K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 369 | 89 | $36.09 | $13K |
| 99458 E&M - Miscellaneous | Office | 358 | 91 | $29.62 | $11K |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 317 | 80 | $97.60 | $31K |
| 96372 Injection Administration | Office | 176 | 66 | $10.23 | $1,801 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 140 | 140 | $121.21 | $17K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 140 | 140 | $17.32 | $2,425 |
| 93010 Electrocardiogram | Facility | 125 | 105 | $6.09 | $762 |
By year: 2022 $466K for 7,235 services; 2023 $413K for 6,919 services; 2024 $481K for 9,024 services.
Medicare prescription drug claims, 2024
In 2024, the drug Appavuchetty Soundappan prescribed most often to Medicare patients was Atorvastatin Calcium, with 6,093 prescriptions and refills. In total Appavuchetty Soundappan wrote 132,362 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 6,093 | 7,072 | 366 | $37K |
| Amlodipine Besylate Generic | 5,161 | 5,875 | 280 | $20K |
| Gabapentin Generic | 4,490 | 5,102 | 315 | $30K |
| Potassium Chloride Generic | 4,362 | 4,930 | 272 | $41K |
| Levothyroxine Sodium Generic | 4,214 | 4,989 | 269 | $24K |
| Eliquis Apixaban | 3,371 | 3,511 | 173 | $672K |
| Pantoprazole Sodium Generic | 3,227 | 4,033 | 284 | $22K |
| Furosemide Generic | 3,219 | 3,585 | 204 | $12K |
| Metoprolol Tartrate Generic | 3,200 | 3,575 | 175 | $12K |
| Sertraline Hcl Generic | 3,076 | 3,223 | 122 | $13K |
| Mirtazapine Generic | 2,991 | 3,008 | 112 | $13K |
| Trazodone Hcl Generic | 2,977 | 3,217 | 159 | $14K |
| Losartan Potassium Generic | 2,716 | 3,008 | 135 | $14K |
| Donepezil Hcl Generic | 2,582 | 2,612 | 91 | $13K |
| Famotidine Generic | 2,273 | 2,559 | 138 | $11K |
Brand drugs: 11,825 claims; generic drugs: 119,752 claims; opioid claims: 1,614.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Appavuchetty Soundappan $742 ($742 in general payments such as food, travel and fees) from 16 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $139.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $139 |
| Beta Bionics, Inc. BBNX | 1 | $119 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $86.78 |
| Sumitomo Pharma America, Inc. 4506.T | 4 | $86.7 |
| Dexcom, Inc. DXCM | 2 | $46.51 |
| Xeris Pharmaceuticals, Inc. | 2 | $44.37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 2 | $30 |
| Novo Nordisk Inc NVO | 1 | $28.75 |
| Abbvie Inc. ABBV | 1 | $28.67 |
| Lilly USA, LLC LLY | 1 | $28.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.